类目: 主页 > 其他 > 1816331-66-4

1816331-66-4

中文名称:
1816331-66-4
中文同义词:
异柠檬酸脱氢酶1(IDH1)突变体抑制剂(GSK864)
英文名称:
GSK864
英文同义词:
GSK864;1H-Pyrazolo[4,3-c]pyridine-3,7-dicarboxamide, 1-[(4-fluorophenyl)methyl]-4,5,6,7-tetrahydro-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrol-2-ylcarbonyl)-, (7S)-;GSK864 >=98% (HPLC)
CAS号:
1816331-66-4
分子式:
C30H31FN6O4
分子量:
558.6
EINECS号:
相关类别:
细胞生物学试剂
Mol文件:
1816331-66-4.mol
储存条件 
2-8°C
形态
powder
颜色
white to beige
旋光性 (optical activity)
[α]/D -66 to -76°, c = 0.5 in methanol
生物活性
GSK864是异柠檬酸脱氢酶1 (IDH1) 突变体抑制剂; 抑制IDH1突变体R132C,R132H和R132G的IC50值分别为8.8,15.2和16.6 nM。
靶点
IC50: 8.8 nM (IDH1 mutants R132C), 15.2 nM (IDH1 mutants R132H), 16.6 nM (IDH1 mutants R132G)
体外研究
GSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with an EC 50 of 320 nM by LCMS/MS analysis.
体内研究
Following intraperitoneal (IP) administration in CD-1 mice, significant concentrations of GSK864 are maintained in peripheral blood samples of mice for up to 24 hours. Analysis of BM cells for expression of markers of early differentiation reveals slightly increased numbers of huCD45 + CD38 + cells in R132C or R132H IDH1 mutant engrafted mice treated with GSK864.
CAS号:1816331-66-4
规   格:10g/20g/100g/1kg
价   格:请咨询卖家
数   量:
联系方式
 15623309010
正品保障
正规发票
闪电发货
满199包邮
英文名:GSK864
外观:
纯度:请咨询卖家
分子式:C30H31FN6O4
分子量:558.6
最小起售量:10g/20g/100g/1kg
中文名称:
1816331-66-4
中文同义词:
异柠檬酸脱氢酶1(IDH1)突变体抑制剂(GSK864)
英文名称:
GSK864
英文同义词:
GSK864;1H-Pyrazolo[4,3-c]pyridine-3,7-dicarboxamide, 1-[(4-fluorophenyl)methyl]-4,5,6,7-tetrahydro-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrol-2-ylcarbonyl)-, (7S)-;GSK864 >=98% (HPLC)
CAS号:
1816331-66-4
分子式:
C30H31FN6O4
分子量:
558.6
EINECS号:
相关类别:
细胞生物学试剂
Mol文件:
1816331-66-4.mol
储存条件 
2-8°C
形态
powder
颜色
white to beige
旋光性 (optical activity)
[α]/D -66 to -76°, c = 0.5 in methanol
生物活性
GSK864是异柠檬酸脱氢酶1 (IDH1) 突变体抑制剂; 抑制IDH1突变体R132C,R132H和R132G的IC50值分别为8.8,15.2和16.6 nM。
靶点
IC50: 8.8 nM (IDH1 mutants R132C), 15.2 nM (IDH1 mutants R132H), 16.6 nM (IDH1 mutants R132G)
体外研究
GSK864 inhibits 2-HG production in R132C IDH1 mutant HT1080 fibrosarcoma cells with an EC 50 of 320 nM by LCMS/MS analysis.
体内研究
Following intraperitoneal (IP) administration in CD-1 mice, significant concentrations of GSK864 are maintained in peripheral blood samples of mice for up to 24 hours. Analysis of BM cells for expression of markers of early differentiation reveals slightly increased numbers of huCD45 + CD38 + cells in R132C or R132H IDH1 mutant engrafted mice treated with GSK864.
商家信息
灵灵九 点击在线咨询 联系电话:15623309010 邮       箱:1287744812@qq.com 公司名称:武汉灵灵九生物科技有限公司
子分类
优质服务
客服电话 1562309010
正品保障 正品保障  提供发票
急速物流 现货闪电  当时发货
售后无忧 不满意退货